JCR Pharma & Alexion Hit Milestone in Neurodegenerative Program
19 Sep 2025 //
PHARMAWEB
Airsupra US: Significant Risk Reduction in Mild Asthma Patients
18 Sep 2025 //
BUSINESSWIRE
SAPHNELO Self-Admin TULIP-SC Ph 3 Trial Meets Endpoint in Lupus
17 Sep 2025 //
BUSINESSWIRE
AstraZeneca`s Asthma Drug Fails `Smoker`s Lung` Study
17 Sep 2025 //
REUTERS
AstraZeneca`s At-Home FluMist TV Spot Under FDA Scrutiny
16 Sep 2025 //
FIERCE PHARMA
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
AstraZeneca pauses $270 Million Investment in Britain
13 Sep 2025 //
REUTERS
ENHERTU Type II Variation Validated in EU for HER2 Solid Tumors
11 Sep 2025 //
BUSINESSWIRE
YolTech Secures $45M in AstraZeneca-CICC Led Series B Funding
11 Sep 2025 //
PR NEWSWIRE
AstraZeneca India Introduces Eculizumab for aHUS, PNH Treatment
09 Sep 2025 //
EXPRESS PHARMA
AstraZeneca Strengthens Tagrisso`s Position Against J&J Rivalry
08 Sep 2025 //
FIERCE PHARMA
Tagrisso Plus Chemo Shows Longest Survival in EGFR Lung Cancer
07 Sep 2025 //
BUSINESSWIRE
FibroGen Sells China Branch to AstraZeneca for $220 Million
02 Sep 2025 //
GLOBENEWSWIRE
AstraZeneca Gears up For Baxdrostat FDA Filing After Ph. 3 Win
02 Sep 2025 //
FIERCE BIOTECH
AstraZeneca to Seek Approval for Blood Pressure Drug
01 Sep 2025 //
REUTERS
University of Michigan Seeks Damages Over AZ`s FluMist Sales
29 Aug 2025 //
FIERCE PHARMA
Lilly, AZ Home in On Sites in Virginia for New Plants
28 Aug 2025 //
FIERCE PHARMA
Polaris Pharmacy Becomes Exclusive US Distributor of FluMist
21 Aug 2025 //
BUSINESSWIRE
China Approves FibroGen China Sale to Astra Zeneca
18 Aug 2025 //
GLOBENEWSWIRE
FLUMIST Intranasal Flu Vaccine Now Available for Home Use
15 Aug 2025 //
BUSINESSWIRE
AstraZeneca Starts DTC Home Delivery of FluMist Vaccine
15 Aug 2025 //
FIERCE PHARMA
AZ, Genentech, Merck top oncology HCP promotions: report
14 Aug 2025 //
FIERCE PHARMA
Nectar Lifesciences Unit VI Earns CGMP Certification from SMDC
12 Aug 2025 //
EQUITYBILL
Sophia Genetics, AstraZeneca Expand AI Breast Cancer Collab
06 Aug 2025 //
PR NEWSWIRE
AZ`s Alexion Highlights gMG in Upcoming Awareness Film
31 Jul 2025 //
FIERCE PHARMA
Symbiosis Achieves 1,000th Injectable Drug Batch Milestone
31 Jul 2025 //
EXPRESSPHARMA
Imfinzi Gets Priority Review, Breakthrough Therapy Status in US
31 Jul 2025 //
INDPHARMAPOST
Trixeo Gets Positive EU CHMP Nod as First GWP Inhaled Medicine
31 Jul 2025 //
INDPHARMAPOST
AstraZeneca, Revna Boost Lung Cancer Treatment Access in Ghana
30 Jul 2025 //
BUSINESSWIRE
AstraZeneca H1 and Q2 2025 Results
29 Jul 2025 //
BUSINESSWIRE
AstraZeneca Abandons Lead TCR Therapy in $200M Neogene Purchase
29 Jul 2025 //
FIERCE BIOTECH
Imfinzi Gets US Priority Review for Early-Stage Gastric Cancers
28 Jul 2025 //
BUSINESSWIRE
AstraZeneca`s Rare Immune Disorder Drug Succeeds in Trial
25 Jul 2025 //
REUTERS
AstraZeneca`s Immune Disorder Drug Succeeds in Late-Stage Trial
24 Jul 2025 //
REUTERS
AstraZeneca Launches Tagrisso Lung Cancer TV Ad
23 Jul 2025 //
FIERCE PHARMA
AstraZeneca Unveils $50 B US Investment as Pharma Tariff Threat
22 Jul 2025 //
REUTERS
AstraZeneca Touts Life-Extension Benefit for Tagrisso Combo
22 Jul 2025 //
PRESS RELEASE
Enhertu + Pertuzumab Get US BTD for HER2+ Breast Cancer
17 Jul 2025 //
BUSINESSWIRE
AstraZeneca for Clearing Protein Fails Main Goal in Late-Stage
17 Jul 2025 //
PRESS RELEASE
Real Chemistry Appoints Three to Catalyze Change
16 Jul 2025 //
FIERCE PHARMA
AstraZeneca Gains CDSCO Approval for Treatment of Bladder Cancer
15 Jul 2025 //
EXPRESSPHARMA
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase 3
15 Jul 2025 //
PRESS RELEASE
Eolas Therapeutics Secures Full Development Rights to AZD4041
10 Jul 2025 //
BUSINESSWIRE
Respiratory Royalty Rally Around Rural COPD Education Drive
09 Jul 2025 //
FIERCE PHARMA
AstraZeneca Inks Third Deal with JCR Pharma For Gene Therapies
09 Jul 2025 //
PRESS RELEASE
Summit, Astrazeneca in Talks Over 15 B Cancer Drug Licensing Deal
05 Jul 2025 //
REUTERS
Imfinzi Approved in EU as First Perioperative Immunotherapy
04 Jul 2025 //
PRESS RELEASE
Modella AI to Advance Oncology Trials With AI Agreement
02 Jul 2025 //
BUSINESSWIRE
Soriot plots move of AZ stock listing to US: The Times
02 Jul 2025 //
FIERCE PHARMA
AstraZeneca Pharma India Approved for Endometrial Cancer
02 Jul 2025 //
EXPRESSPHARMA
Onco-Innovations Welcomes AstraZeneca`s Interest in PROmAI
27 Jun 2025 //
ACCESSWIRE
AstraZeneca Expands Bengaluru Hub with ?166 Cr Investment
26 Jun 2025 //
ECONOMICTIMES
US CDC vaccine panel postpones vote on RSV therapies
25 Jun 2025 //
REUTERS
DATROWAY® approved in US for advanced EGFR-mutated lung cancer
24 Jun 2025 //
BUSINESSWIRE
BMJ Finds More Irregularities in Trial Data for Az`s Brilinta
24 Jun 2025 //
FIERCE PHARMA
Datroway approved in US as first TROP2 Therapy for Lung Cancer
23 Jun 2025 //
BUSINESSWIRE
Eccogene Starts Phase 1b Trial of AZD5004/ECC5004 in China
18 Jun 2025 //
GLOBENEWSWIRE
Sheffield & Astra Zeneca Develop for Inverse Protein Folding
18 Jun 2025 //
EXPRESSPHARMA
AZ touts Ultomiris Results in Post-Transplant Complication Trial
17 Jun 2025 //
FIERCE PHARMA
AstraZeneca Signs AI Research Deal with CSPC for Chronic Disease
14 Jun 2025 //
REUTERS